112 related articles for article (PubMed ID: 5652623)
1. [Behavior and prognostic significance of serum ceruloplasmin in relation to the histopathological aspect of Hodgkin's disease].
Pisi E; Di Feliciantonio R; Figus E; Ferri S
Minerva Med; 1968 Feb; 59(17):944-52. PubMed ID: 5652623
[No Abstract] [Full Text] [Related]
2. Ceruloplasmin in Hodgkin's disease.
Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of beta-2-microglobulin in Hodgkin disease in young adults].
Fleury J; Tortochaux J; Legros M; Cure H; Kwiatkowski F; Ferrière JP; Travade P; Dionet C; Gaillard G; Chassagne J
Bull Cancer; 1994 Jul; 81(7):625-31. PubMed ID: 7742606
[TBL] [Abstract][Full Text] [Related]
4. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
Margerison AC; Mann JR
Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
[TBL] [Abstract][Full Text] [Related]
5. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease].
Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A
Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612
[No Abstract] [Full Text] [Related]
6. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
7. Epithelioid granulomas in Hodgkin's disease--prognostic significance.
Chopra R; Rana R; Zachariah A; Mahajan MK; Prabhakar BR
Indian J Pathol Microbiol; 1995 Oct; 38(4):427-33. PubMed ID: 9726157
[TBL] [Abstract][Full Text] [Related]
8. Value of laboratory indicators in Hodgkin's disease: preliminary results.
Ray GR; Wolf PH; Kaplan HS
Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
[No Abstract] [Full Text] [Related]
9. Prognostic significance of serum albumin in Hodgkin's disease.
Gobbi PG; Cavalli C; Gendarini A; Bonfichi M; Galeone F; Inzoli A; Ascari E
Haematologica; 1986; 71(2):95-102. PubMed ID: 3087839
[No Abstract] [Full Text] [Related]
10. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
[TBL] [Abstract][Full Text] [Related]
11. [Serum complement level in Hodgkin's disease].
Hamladji RM; Belhani M; Irunberry J; Benabadji M; Colonna P
Nouv Rev Fr Hematol; 1972; 12(5):673-81. PubMed ID: 4120941
[No Abstract] [Full Text] [Related]
12. [Serum copper content and ceruloplasmin activity in children with lymphogranulomatosis].
Dmitrieva LV
Vopr Okhr Materin Det; 1967 Feb; 12(2):37-40. PubMed ID: 5611374
[No Abstract] [Full Text] [Related]
13. [Prognostic disease symptoms and signs in Hodgkin's disease and their importance in the therapy of the disease].
Musshoff K; Boutis L; Laszlo AM; Laszlo I
Strahlentherapie; 1966 Dec; 131(4):482-504. PubMed ID: 5992388
[No Abstract] [Full Text] [Related]
14. [Liver involvement in Hodgkin's disease. Histopathological study with clinico-biochemical correlation].
Mugüerza JM; Rivas C; Hernández Guío C; Oliva H
Rev Clin Esp; 1988 Jul; 183(3):110-9. PubMed ID: 3187122
[No Abstract] [Full Text] [Related]
15. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
Sirsat AV; Raste AS; Talavdekar RV; Advani SH
Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
[No Abstract] [Full Text] [Related]
16. Serum ceruloplasmin levels in patients of leukaemias, Hodgkin's and non-Hodgkin's lymphomas.
Aggarwal AK; Sanwalka AB; Vadehra PL; Prabhakar BR
Indian J Pathol Microbiol; 1984 Oct; 27(4):347-52. PubMed ID: 6534868
[No Abstract] [Full Text] [Related]
17. [Relevance of certain factors in the effectiveness of chemoradiotherapy for Hodgkin's disease].
Kanaev SV; Gershanovich ML; Pozharisskiĭ KM; Girshovich MM; Golovanov SG
Vopr Onkol; 2005; 51(1):56-9. PubMed ID: 15909808
[TBL] [Abstract][Full Text] [Related]
18. The pretreatment peripheral blood lymphocyte count in 1100 patients with Hodgkin's disease: the prognostic significance and the relationship to the presence of systemic symptoms.
MacLennan KA; Hudson BV; Jelliffe AM; Haybittle JL; Hudson GV
Clin Oncol; 1981 Dec; 7(4):333-9. PubMed ID: 7318276
[No Abstract] [Full Text] [Related]
19. Prognostic significance of soluble adhesion molecules in Hodgkin's disease.
Syrigos KN; Salgami E; Karayiannakis AJ; Katirtzoglou N; Sekara E; Roussou P
Anticancer Res; 2004; 24(2C):1243-7. PubMed ID: 15154654
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic molecules in Hodgkin's disease: results from sequential serum analysis.
Passam FH; Alexandrakis MG; Moschandrea J; Sfiridaki A; Roussou PA; Siafakas NM
Int J Immunopathol Pharmacol; 2006; 19(1):161-70. PubMed ID: 16569354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
